FDA Engineering Presentation1 Division of Cardiovascular Devices Panel Meeting Center for Devices & Radiological Health April 22, 2005 Kachi Enyinna, M.S.,

Slides:



Advertisements
Similar presentations
Public Health Issues Related to Mutually Conforming Labeling: CDRH Perspective Miriam C. Provost, Ph.D. Office of Device Evaluation Center for Devices.
Advertisements

HEARTSTRINGTM Proximal Seal System
Comparison of Surgical Treatments for Blocked Arteries By-Pass Surgery with Heart-Lung Machine By-Pass Surgery using Off-Pump Technique Angioplasty with.
FDA Clinical Presentation1 Cardica Proximal Anastomosis System 510k Wolf Sapirstein MPH, FACS Clinical Review FDA/CDRH/ODE.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Cook Zenith® AAA Endovascular Graft and the H&L-B One-Shot  Introduction System P April 10, 2003 FDA Circulatory System Devices Panel Meeting Gaithersburg,
1 Statistical Review DRAFT Barbara Krasnicka, Ph.D. FDA, CDRH Division of Biostatistics.
GU Advisory Panel Meeting Nocturnal Home Hemodialysis Draft Carolyn Y. Neuland, Ph.D. Chief, Gastroenterology and Renal Devices Branch Division of Reproductive,
PERCUTANEOUS PULMONARY VALVE REPLACEMENT:
What Are the FDA Requirements for Submitting an IDE?
Bypass graft to the contralateral internal jugular vein for venous outflow obstruction of a functioning hemodialysis access fistula  Jeff L. Myers, MD,
Periprosthetic leak and rupture after endovascular repair of abdominal aortic aneurysm: The significance of device design for long-term results  Kirsten.
Carolyn D. Vaughan FDA Lead Reviewer / Mechanical Engineer
Valve Durability Considerations: Fluid Dynamic Principles, Assessment Techniques, Predictors, and Minimum Standards Jorge H. Jimenez, Ph.D. Georgia Institute.
Endurant: A New Generation Endograft
University of Pennsylvania
Renal Unit-Careggi University Hospital-Florence-Italy
Surgical Therapy for Anomalous Aortic Origin of the Coronary Arteries
The Syncardia Total Artificial Heart: Implantation Technique
Surgical Treatment of Anomalous Aortic Origin of Coronary Arteries: The Reimplantation Technique and Its Modifications  Thierry Carrel, MD  Operative.
Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy  Tom R. Karl, MS, MD  Operative Techniques in Thoracic and Cardiovascular.
Improving Coronary Artery Bypass Surgery
Percutaneous device closure of a pseudoaneurysm arising from the junction of the innominate artery and the aorta  Dawn C. Scantlebury, MBBS, Oluseun O.
Nicholas D. Andersen, MD, Judson B. Williams, MD, MHS, Jennifer M
Treatment of postoperative distal anastomotic endoleak with the Amplatzer Vascular Plug II in chronic aortic arch dissection: A case report  Iskander.
Richard J. Myung, MD, Michael E. Halkos, MD, John D. Puskas, MD 
Endovascular grafts for noninfected aortoiliac anastomotic aneurysms
Experimental study of a novel mechanical connector for sutureless open arterial anastomosis  Salam Abou Taam, MD, Jean-François Garbé, MD, Mourad Boufi,
Extra-anatomic Bypass Graft for Recurrent Aortic Arch Obstruction
Novel sutureless telescoping anastomosis revascularization technique of supra-aortic vessels to simplify combined open endovascular procedures in the.
Flow dynamics of the St Jude Medical Symmetry aortic connector vein graft anastomosis do not contribute to the risk of acute thrombosis  A. Redaelli,
An experimental model of saphenous vein-to-coronary artery anastomosis with the St. Jude medical stainless steel connector  Hartzell V Schaff, MD, Kenton.
Simplified total arch repair with a stented graft for acute DeBakey type I dissection  Enyi Shi, MD, PhD, Tianxiang Gu, MD, PhD, Yang Yu, MD, Chun Wang,
A new modified Bentall procedure: the flanged technique
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting  David P. Taggart, MD, PhD, Yanai Ben Gal, MD, Belinda.
Femoral vein homograft for neoaortic reconstruction in the Norwood stage 1 operation: A follow-up study  Thomas J. Seery, MD, Pranava Sinha, MD, David.
Enabling sutureless vascular bypass grafting with the exovascular sleeve anastomosis  David W. Chang, MD, Allen Chan, MD, R.Armour Forse, MD, PhD, William.
Wolfgang F. Konertz, Alexandros Sidiropoulos, Jianshi Liu 
One-shot aortic anastomosis with an automatic stapling gun
Early Clinical Results With a Magnetic Connector for Distal Coronary Artery Anastomoses  Calin Vicol, MD, Sandra Eifert, MD, Martin Oberhoffer, MD, Peter.
The coronary artery bypass conduit: II
Paul P. Urbanski, MD, PhD, Vadim Irimie, MD, Lukas Lehmkuhl, MD, PhD 
Direct innominate artery cannulation: An alternate technique for antegrade cerebral perfusion during aortic hemiarch reconstruction  Arminder S. Jassar,
Periprosthetic leak and rupture after endovascular repair of abdominal aortic aneurysm: The significance of device design for long-term results  Kirsten.
Lars G. Svensson, MD, PhD, Gregory D
The Journal of Thoracic and Cardiovascular Surgery
K. Jane Grande-Allen, PhD, Richard P. Cochran, MD, Per G
Sumanth Kidambi, MD, Yasuhiro Shudo, MD, PhD, Michael D. Dake, MD, Y
Aortic cannulation with a single purse-string suture
Sameh M. Said, MD, Harold M. Burkhart, MD, Joseph A
Minimizing aortic manipulation during OPCAB using the symmetry aortic connector system for proximal vein graft anastomoses  Friedrich S Eckstein, MD,
Bao-Ngoc Nguyen, MD, Richard F
Raphael Coscas, MD, Roy K. Greenberg, MD, Kathryn Pfaff, BS 
Elephant Trunk Anastomosis Proximal to Origin of Innominate Artery in Total Arch Replacement  Kazuhiro Taniguchi, MD, PhD, Koichi Toda, MD, PhD, Hiroki.
Port access video-assisted proximal anastomosis with the symmetry aortic connector in MIDCABG procedure  Michal Semrad, MD, PhD, Martin Stritesky, MD,
C Lauder, MBChB, A Kelly, BSc, M. M Thompson, MD, FRCS, N. J
Initial experience with sutureless proximal anastomoses performed with a mechanical connector leading to clampless off-pump coronary artery bypass surgery 
Alternative techniques for management of distal anastomoses of aortofemoral and iliofemoral endovascular grafts  Reese A. Wain, MD, Ross T. Lyon, MD,
Bypass graft to the contralateral internal jugular vein for venous outflow obstruction of a functioning hemodialysis access fistula  Jeff L. Myers, MD,
Dolores F. Cikrit, MD, Michael C. Dalsing, MD, Stephen G
L. Hornik, G. Tenderich, K. Minami, D. Fassbender, T. O. Schulz, B
Follow-up evaluation after renal artery bypass surgery with use of carbon dioxide arteriography and color-flow duplex scanning  Timothy R.S. Harward,
Kagami Miyaji, MD, Randall K Wolf, MD, John B Flege, MD 
The St Jude Medical symmetry aortic connector system for proximal vein graft anastomoses in coronary artery bypass grafting  Friedrich S. Eckstein, MD,
Surgical correction of abdominal aortic coarctation and hypertension
Surgical Strategy to Establish a Dual-Coronary System for the Management of Anomalous Left Coronary Artery Origin From the Pulmonary Artery  Bahaaldin.
The treatment of recurrent aortic prosthetic detachment with modified Bentall procedure: Results of two cases  Chong Zhang, MD, Yiming Ni, MD, Liping.
Arch-first technique for aortic arch aneurysm repair through median sternotomy  Motonobu Nishimura, MD, Shigeaki Ohtake, MD, Yoshiki Sawa, MD, Toshiki.
Pitfalls and key lessons with the symmetry proximal anastomotic device in coronary artery bypass surgery  Thierry P Carrel, MD, Friedrich S Eckstein,
Replacement of a Stented Biologic Prosthesis Within an Aortic Valved Conduit  Giuseppe Gatti, MD, Alessandro Moncada, MD, Alessandro Minati, MD, Aniello.
Presentation transcript:

FDA Engineering Presentation1 Division of Cardiovascular Devices Panel Meeting Center for Devices & Radiological Health April 22, 2005 Kachi Enyinna, M.S., Scientific Reviewer, Circulatory Support and Prosthetics Devices Branch Kachi Enyinna, M.S., Scientific Reviewer, Circulatory Support and Prosthetics Devices Branch Barbara Krasnicka, Ph.D., Statistician, Office Surveillance & Biometrics Barbara Krasnicka, Ph.D., Statistician, Office Surveillance & Biometrics Wolf Sapirstein, MD, Medical Officer, Division of Cardiovascular Devices Wolf Sapirstein, MD, Medical Officer, Division of Cardiovascular Devices

FDA Engineering Presentation2 PAS-Port Proximal Anastomosis System by Cardica Inc.

FDA Engineering Presentation3 Indications for Use Cardica’s proposed indication for use: –The PAS-Port® System is intended to create an everting anastomosis (end-to- side) between the aorta and autologous vein graft. Predicate: St. Jude Medical Symmetry Aortic Clip

FDA Engineering Presentation4 PAS-Port® Proximal Anastomosis System PAS-Port System consists of: PAS-Port System consists of: –Delivery System – used to attach conduit. –Implant – stainless steel tubing used to connect veins (conduit) to vascular vessels in an end-to-side fashion.

FDA Engineering Presentation5 Comparison to Predicate The PAS-Port was designed to be similar to the St. Jude Symmetry. The PAS-Port was designed to be similar to the St. Jude Symmetry. Both systems deliver and implant a metallic star shape connector for hemostatic anastomosis between the aorta and saphenous vein during CABG surgery. Both systems deliver and implant a metallic star shape connector for hemostatic anastomosis between the aorta and saphenous vein during CABG surgery. No new technological characteristics differentiating the two systems. No new technological characteristics differentiating the two systems.

FDA Engineering Presentation6 PAS-Port vs Symmetry Absence of conduit Cannulation Absence of conduit Cannulation Full thickness aorta and conduit capture by the device Full thickness aorta and conduit capture by the device Single action for delivery and aortotomy Single action for delivery and aortotomy Reduced Profile Reduced Profile Reduced amount of metal in blood path: Reduced amount of metal in blood path: –PAS-Port = in 2 –Symmetry = in 2

FDA Engineering Presentation7 PAS-Port vs Symmetry The controversial features of the predicate do persist however, with the PAS-Port. The controversial features of the predicate do persist however, with the PAS-Port.

FDA Engineering Presentation8 PAS-Port vs Symmetry Exposure of metal to blood reduced but still present Exposure of metal to blood reduced but still present PAS-PortSymmetry

FDA Engineering Presentation9 PAS-Port vs Symmetry Non-compliant annular containment exist at orifice with stent like scaffolding is still conducive to kinking. Non-compliant annular containment exist at orifice with stent like scaffolding is still conducive to kinking. PAS-PortSymmetry Hand Sewn Suture

FDA Engineering Presentation10 History While there are cleared devices, FDA convened an Advisory Panel one year ago to clarify clearance requirements for anastomotic devices. While there are cleared devices, FDA convened an Advisory Panel one year ago to clarify clearance requirements for anastomotic devices. Since that time, the St. Jude Medical Symmetry device has been withdrawn from the market, Bypass Maakafim CorLink AAD has not been commercialized, and Coalescent U-Clip is marketed as a suture. Since that time, the St. Jude Medical Symmetry device has been withdrawn from the market, Bypass Maakafim CorLink AAD has not been commercialized, and Coalescent U-Clip is marketed as a suture.

FDA Engineering Presentation11 Performance Testing Summary A.Functional Testing Summary 1.Formation of Anastomosis 2.Leakage at Site of Anastomosis 3.Poke Through Test 4.Pull Through Test 5.Aortic Plug Capture 6.Implant Pull Out Test 7.Hard Stop

FDA Engineering Presentation12 Performance Testing Summary (cont’d) Pre-Fire Tests 8.Knob and Switch 9.Cartridge Lock 10.Safety Switch

FDA Engineering Presentation13 Performance Testing Summary (cont’d) B.Fatigue Testing of Implant –Finite Element Analysis –Physical Fatigue Testing –Corrosion Resistance C.Pre-Clinical (Animal) Testing D.Clinical Testing

FDA Engineering Presentation14 Device Modifications Study I The device implant used in Study I is technically different from the implant used in Cohort II study. The device implant used in Study I is technically different from the implant used in Cohort II study. In early submission, sponsor notes that “minor changes in the pre-shaped implant geometry and implant shaping procedures” were performed. In early submission, sponsor notes that “minor changes in the pre-shaped implant geometry and implant shaping procedures” were performed.

FDA Engineering Presentation15 Summary of Device Modifications Attachment 9 of original 510(k) outlines the several modifications on the PAS-Port implant. Attachment 9 of original 510(k) outlines the several modifications on the PAS-Port implant.